 Home > Food News > Nutrition News > Incyte announced that the FDA has approved the marketing of the FGFR inhibitor Pemazyre (pemigatinib, pemitinib).

Incyte announced that the FDA has approved the marketing of the FGFR inhibitor Pemazyre (pemigatinib, pemitinib).

 Last Update: 2022-09-09
 Source: Internet
 Author: User

Tags

phase perfect

topoisomerase ii inhibitors

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On August 26, Incyte announced that the FDA has approved the marketing of the FGFR inhibitor Pemazyre (pemigatinib, pemitinib) for the treatment of adult patients

Pemetinib in the FIGHT-203 study showed a persistent and high CR rate and CCyR rate: in patients in the chronic phase with or without EMD (N=18), the CR rate was 78% (14/18; 95% CI 52, 94)
。 In patients with or without EMD in the blast phase (N=4), two patients achieved CR
.
In patients with only EMD (N=3), one patient achieved CR
.
For all patients (N = 28), the complete cytogenetic response (CCyR) was 79% (22/28; 95% CI: 59, 92)
。

Pemetinib has been approved in the United States, the European Union, Japan, and China for the treatment of previously treated adult patients
with FGFR2 fusion or other rearrangements of unresectable, locally advanced, or metastatic cholangiocarcinoma.
Cinda owns the clinical development and commercialization rights
of the product in Chinese mainland and in Hong Kong, Macau and Taiwan.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Factory Provide Citicoline Sodium CAS 33818-15-4 Cdp-Choline Sodium Citicoline Sodium

CAS No.: 33818-15-4

Pharmacy Grade

$100-101/KG FOB

Food Grade Anti Aging CAS 23111-00-4 99% Nicotinamide Riboside Chloride Nrc Nr-Cl Powder

CAS No.: 23111-00-4

Food Grade

$200-201/KG FOB

Cartilage extract

CAS No.:

$75-89/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.